Search Results
252 items found for "Keltic Pharma Therapeutics"
- 📰 GPCR Weekly News - January 2 to 8, 2023
Enter into Multitarget Antibody Discovery Research Collaboration Neurocrine Biosciences and Voyager Therapeutics
- Interacting binding insights and conformational consequences of the differential activity of...
way for understanding the CBD pharmacology at a molecular level and aid in harnessing its potential therapeutic
- 📰 GPCR Weekly News, March 18 to 24, 2024
Subject in Phase 1 Trial with HTL0033744, an EP4 Agonist for Inflammatory Bowel Disease (IBD) Domain Therapeutics
- Unveiling GPCR Priming: The Hidden Synergy in Cellular Signalling
implications for drug development, as targeting these non-cognate interactions could lead to novel therapeutic
- TM5-TM6: structural switches that modulate the coupling of serotonin receptors to Gs or Gi
understanding how serotonin receptors, one of the largest subfamilies of class A GPCRs and potential therapeutic
- HBx induces hepatocellular carcinogenesis through ARRB1-mediated autophagy to drive the G 1/S cycle
modulating autophagy and the CDKN1B-CDK2-CCNE1-E2F1 axis and indicate that ARRB1 may be a potential therapeutic
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
revolution of biased signalling of GPCRs comes the possibility of designing drugs that selectively activate therapeutically analyzing drug-target interactions and disease pathways, AI can identify potential candidates that may have therapeutic
- 📰 GPCR Weekly News - January 9 to 15, 2023
Foundation is awarding DKK 174 million in grants to seven ‘mind-bending’ research collaborations GPCR Therapeutics
- Dr. GPCR University registration is now open! Secure your spot now!
the atomic-level quaternary structure of short-lived GPCR oligomers in live cells Industry News Confo Therapeutics
- Exploring the Breakthroughs in GPCR Research
GPCRs remain one of the most prolific and fertile therapeutic drug targets.
- 📰 GPCR Weekly News, December 4 to 10, 2023
Muscarinic Agonist Candidates in Phase 1 Clinical Studies AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics
- 📰 GPCR Weekly News, February 13 to 19, 2023
GPCR Binders, Drugs, and more Novel targets for potential therapeutic use in Diabetes mellitus.
- 📰 GPCR Weekly News, November 6 to November 12, 2023
Jefferies Healthcare Conference in London Sosei Heptares and Kallyope Nominate First GPCR Target for Therapeutic
- 📰 GPCR Weekly News, March 6 to 12, 2023
Domain Therapeutics was nominated for the Trophée de l'Innovation Technologique (Technological Innovation
- 📰 GPCR Weekly News, January 8 to 14, 2024
MCF7 breast cancer cells Reviews, GPCRs, and more The multifaceted functions of β-arrestins and their therapeutic
- Transmembrane domains of GPCR dimers – a novel hot spot for drug discovery
GPCR dimers are therefore emerging drug targets in different therapeutic areas including depression,
- 📰 GPCR Weekly News, April 24 to 30, 2023
GPCR Events, Meetings, and Webinars ASPET 2023 - American Society for Pharmacology and Experimental Therapeutics
- 📰 GPCR Weekly News, December 18 to 31, 2023
Morgan Healthcare Conference Andrew Hopkins appointed CBE by HM King Charles III Voyager Therapeutics
- 📰 GPCR Weekly News, May 13 to 19, 2024
Mark your calendar for the GPCRs as Therapeutic Targets symposium on October 11th, 2024.
- Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling
continue to propel our quest to unravel the complexities of GPCR signaling and pave the way for novel therapeutic
- 📰 GPCR Weekly News, March 4 to 10, 2024
development GPCR Events, Meetings, and Webinars March 13 - 15 | Biologics 2024 March 13 - 15 | 9th German Pharm-Tox
- 📰 GPCR Weekly News
GPCRs in Neuroscience CGRP physiology, pharmacology, and therapeutic targets: Migraine and beyond.
- Unlocking Cell's Secrets: Spontaneous β-Arrestin-Membrane Preassociation Drives Receptor-Activation
Pharmacology & therapeutics, 89(2), 139–147. https://doi.org/10.1016/s0163-7258(00)00107-8
- 📰 GPCR Weekly News, February 12 to 18, 2024
February 20, 2024 | Career Opportunities in Pharmacology and Drug Discovery March 13 - 15 | 9th German Pharm-Tox
- 📰 GPCR Weekly News, January 15 to 21, 2024
Conference and Exhibition February 11 - 14, 2024 | 2024 BPS Annual Meeting NEW March 13 - 15 | 9th German Pharm-Tox
- Feeder or trigger – CCR2 as a scavenger and regulator of cell migration
This scavenging function should be considered when evaluating the safety and therapeutic efficacy of
- Decoding β-Arrestins: from Structure to function
within distinct cell types or tissues, will undoubtedly provide valuable guidance for advancing such therapeutic
- Structural landscape of the Chemokine Receptor system
binding and receptor activation will pave the way for significant advancements in the development of therapeutics